BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 27, 2016
View Archived Issues
Novo Nordisk announces the launch of Tresiba in the U.S.
Read More
A new patent listed and additional orphan drug designation granted for Procysbi in the U.S.
Read More
Factor VII deficiency corrected with gene therapy in large animal model
Read More
OncoTherapy begins phase Ib trials of peptide vaccine for malignant mesothelioma
Read More
Cleveland BioLabs starts a phase II trial of CBLB-612 in the Russian Federation
Read More
Novavax announces proposed offering of USD 200 million convertible senior notes
Read More
CE Mark for Quidel's Sofia S. pneumoniae Fluorescent Immunoassay
Read More
Faron Pharmaceuticals listed in London Stock Exchange AIM market
Read More
Living Cell Technologies reports findings from phase I/IIa study of NTCell for Parkinson's disease
Read More
FDA approves Dako's PD-L1 IHC 28-8 pharmDx test for use in melanoma
Read More
FDA clearance for ChloraDerm antimicrobial film dressing
Read More
CMV vaccine is safe and effective in stem cell transplant patients
Read More
Study unveils the potential of exosomes as therapeutic agents and delivery system for gene therapies
Read More
Ferring Pharmaceuticals and Karolinska Institutet to establish human microbiome research center
Read More
Afatinib demonstrates superiority to gefitinib on PFS in LUX-Lung 7 trial
Read More
Johnson & Johnson reflects on highlights of fourth quarter 2015
Read More
University of Texas System patents mitochondrial GLS1 inhibitors
Read More
Transplanted pancreatic beta-like cells exhibited glucose-stimulated insulin secretion in mice
Read More
FDA puts Medivation's pidilizumab on clinical hold
Read More
BBI-608 plus paclitaxel shows promise for the treatment of refractory pancreatic cancer
Read More
Prima BioMed starts phase I study of IMP-321 for the treatment of melanoma
Read More
